ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,670Medicare Part D Prescriptions Filled, Including Refills

Rank: 32 out of 569

$386K Total Retail Price of All Prescriptions

Rank: 83 out of 569

424 Patients Receiving at Least One Drug in Part D
66% Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in New Mexico
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

10% of this provider’s 424 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 424 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LISINOPRIL 548 391 106 1 2
LEVOTHYROXINE SODIUM 524 417 88 2 1
METFORMIN HCL 397 232 78 3 5
OMEPRAZOLE 383 202 74 4 4
AMLODIPINE BESYLATE 279 233 54 5 6
GABAPENTIN 272 160 55 6 9
LOVASTATIN 268 200 57 7 12
HYDROCHLOROTHIAZIDE 261 214 60 8 8
SIMVASTATIN 252 180 48 9 3
LOSARTAN POTASSIUM 201 135 41 10 13
CITALOPRAM HBR 184 75 30 11 23
FUROSEMIDE 177 141 37 12 11
HYDROCODONE-ACETAMINOPHEN 170 88 29 S3 13 7
METOPROLOL TARTRATE 162 139 35 14 14
PROAIR HFA 139 54 46 15 30
ZOLPIDEM TARTRATE 138 71 27 16 18
TRAZODONE HCL 134 78 23 17 24
ATORVASTATIN CALCIUM 130 109 28 18 10
ATENOLOL 120 95 23 19 19
QUINAPRIL HCL 116 97 15 20 108
WARFARIN SODIUM 112 94 20 21 27
MORPHINE SULFATE ER 111 <11 <11 S2 22 62
TRAMADOL HCL 111 58 25 22 25
OXYCODONE HCL 109 40 22 S2 24 31
SERTRALINE HCL 102 19 18 25 20
RANITIDINE HCL 99 70 16 26 29
GLYBURIDE 85 53 16 R 27 74
POTASSIUM CHLORIDE 85 54 18 27 26
IBUPROFEN 84 38 32 29 32
LANTUS 83 41 19 30 46
ALENDRONATE SODIUM 82 69 16 31 16
OXYCODONE-ACETAMINOPHEN 81 38 13 S2 32 47
GLIPIZIDE 76 71* 19 33 35
CLOPIDOGREL 73 68* 11 34 34
AMOXICILLIN 71 42 52 35 113
ADVAIR DISKUS 69 37 16 36 52
FLUTICASONE PROPIONATE 68 43 29 37 17
CYCLOBENZAPRINE HCL 66 <11 17 R 38 60
ACETAMINOPHEN-CODEINE 57 28 12 S3 39 90
PANTOPRAZOLE SODIUM 57 22 12 39 36
PAROXETINE HCL 54 33 12 41 55
POLYETHYLENE GLYCOL 3350 53 <11 <11 42 122
NOVOLOG 52 <11 <11 43 156
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 5, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.